Pacific Biosciences of California, Inc. (PACB)

1,6500 +0,0500 (+3,12%) Al cierre: 04:00PM EDT

Pacific Biosciences of California, Inc.

1305 O’Brien Drive
Menlo Park, CA 94025
United States
650 521 8000
https://www.pacb.com

Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 796

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Christian O. Henry M.B.A.	President, CEO & Director	1,1M	N/A	1968
Ms. Susan G. Kim	Chief Financial Officer	564,87k	N/A	1976
Mr. Mark Van Oene	Chief Operating Officer	772,11k	N/A	1973
Mr. Jeff Eidel	Chief Commercial Officer	435,62k	N/A	1977
Dr. Stephen Turner Ph.D.	Co-Founder	341,25k	N/A	1968
Trevin Rard	Head of Investor Relations	N/A	N/A	N/A
Dr. Brett Atkins J.D., Ph.D.	General Counsel & Corporate Secretary	N/A	N/A	N/A
Ms. Natalie Welch	Chief People Officer	N/A	N/A	N/A
Dr. Denis Zaccarin Ph.D.	Senior Vice President of Research & Development	510,77k	4,34M	1966
Mr. Mike Goloubef	Senior Vice President of Manufacturing & Quality	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Gobierno corporativo

El ISS Governance QualityScore de Pacific Biosciences of California, Inc., a día 29 de abril de 2024, es 5. Las puntuaciones base son Auditoría: 6; Tablero: 3; Derechos de los accionistas: 4; Compensación: 7.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.